Urologic Oncology
Research activity is centered on muscle-invasive bladder cancer in patients considered for radical cystectomy and orthotopic neobladder reconstruction, with attention to surgical reconstruction in the setting of advanced bladder disease.
- Muscle-invasive bladder cancer
- Radical cystectomy
- Orthotopic neobladder reconstruction
The clinical focus includes reconstructive management after bladder removal, with interest in restoring urinary function through bladder replacement strategies.
Reconstructive Urology
The sponsor’s clinical interest extends to neobladder surgery and the use of autologous urothelial cells in urinary tract reconstruction, reflecting a therapeutic emphasis on tissue-based restoration of the lower urinary system.
- Neobladder surgery
- Autologous urothelial cells
- Urinary tract reconstruction
This area is closely linked to postoperative functional recovery in patients requiring complex bladder replacement procedures.
Cell Therapy
Phosprint P.C. is involved in research on expanded autologous cells for surgical implantation, with a specific focus on urothelial regeneration and tissue repair within the urinary tract.
- Expanded autologous cells
- Urothelial regeneration
- Tissue repair
The therapeutic interest lies in using patient-derived cells to support structural reconstruction during bladder replacement surgery.
Bioprinting Technologies
Clinical research also covers bioprinted tissue constructs and the application of a 3D bioprinter in the operative setting, highlighting interest in device-enabled regenerative approaches for urologic surgery.
- Bioprinted tissue constructs
- 3D bioprinter
- Device-enabled regenerative surgery
The work is directed toward integrating engineered cellular material into reconstructive procedures for bladder substitution.
